Concord Drugs Q4 Results

  • BSE: 538965
  • NSE: -
  • ISIN: INE858L01010
  • Sector: Biotechnology & Drugs
BSE
34.75-1.25 (-3.47%)
Volume12.68 K
Updated: Tue 26 Nov, 2024 | 15:29:55
NSE
This stock is not traded on NSE
Today: 33.94
37.90
52-Wk: 30.59
61.50

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Concord Drugs Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 15.6413.53-%12.31-%
    Selling/ General/ Admin Expenses Total 1.691.31-%1.30-%
    Depreciation/ Amortization 0.390.38-%0.33-%
    Other Operating Expenses Total 0.351.07-%-0.75-%
    Total Operating Expense 15.6912.46-%11.67-%
    Operating Income -0.041.06-%0.64-%
    Net Income Before Taxes -0.550.62-%0.14-%
    Net Income -0.340.45-%0.16-%
    Diluted Normalized EPS -0.340.52-%0.15-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts